An Interprofessional Approach to Achieving Opioid Guideline Recommendations at a Primary Care Clinic Wade Tugman, David Stewart, Brooklyn Nelson, Emily Russell ETSU - Bill Gatton College of Pharmacy - PGY2 Amb. Care - Johnson City, TN
Background/Purpose: Determine if a pharmacist integrated into a primary care clinic as part of an inter-professional team affects the clinic_x0019_s success in adhering to the Center for Disease Control_x0019_s 2016 Guideline for Prescribing Opioids for Chronic Pain.
Methodology: The study population will include primary care patients who were on high dose (MME >90 mg) chronic opioid therapy (defined as > 3 months) as of February 1, 2017. MMEs will be assessed for each study subject at index date (February 1, 2017) and at exit date (February 1, 2018) for both the intervention group (pharmacist integrated into the practice) and the control group (clinics that currently do not have pharmacist at the clinic). Other outcomes to be assessed are: change in naloxone prescriptions, change in compliance to urine drug screening per CDC guideline recommendations (yearly), and change in the number of concurrently prescribed benzodiazepines
Presentation Objective: Review the impact that a pharmacist as part of an inter-professional team in a primary care clinic can have on clinic compliance to the Center for Disease Control_x0019_s 2016 Guideline for Prescribing Opioids for Chronic Pain.
Self-Assessment: Which of the following are measures that an embedded pharmacist in a primary care clinic can have a positive impact on in regard to opioid stewardship?
